Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Feb;43(2):169–176. doi: 10.1038/bjc.1981.25

Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study.

L Hardell, M Eriksson, P Lenner, E Lundgren
PMCID: PMC2010513  PMID: 7470379

Abstract

A number of men with malignant lymphoma of the histiocytic type and previous exposure to phenoxy acids or chlorophenols were observed and reported in 1979. A matched case-control study has therefore been performed with cases of malignant lymphoma (Hodgkin's disease and non-Hodgkin lymphoma). This study included 169 cases and 338 controls. The results indicate that exposure to phenoxy acids, chlorophenols, and organic solvents may be a causative factor in malignant lymphoma. Combined exposure of these chemicals seemed to increase the risk. Exposure to various other agents was not obviously different in cases and in controls.

Full text

PDF
169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelson O. A note on observational bias in case-referent studies in occupational health epidemiology. Scand J Work Environ Health. 1980 Mar;6(1):80–82. doi: 10.5271/sjweh.2630. [DOI] [PubMed] [Google Scholar]
  2. Axelson O. The case-referent (case-control) study in occupational health epidemiology. Scand J Work Environ Health. 1979 Jun;5(2):91–99. doi: 10.5271/sjweh.2654. [DOI] [PubMed] [Google Scholar]
  3. Bjorkholm M., Holm G., Mellstedt H. Immunologic profile of patients with cured Hodgkin's disease. Scand J Haematol. 1977 May;18(5):361–368. doi: 10.1111/j.1600-0609.1977.tb02090.x. [DOI] [PubMed] [Google Scholar]
  4. Greene M. H., Brinton L. A., Fraumeni J. F., D'Amico R. Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet. 1978 Sep 16;2(8090):626–627. doi: 10.1016/s0140-6736(78)92845-3. [DOI] [PubMed] [Google Scholar]
  5. Greim H., Bonse G., Radwan Z., Reichert D., Henschler D. Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation. Biochem Pharmacol. 1975 Nov 1;24(21):2013–2017. doi: 10.1016/0006-2952(75)90396-2. [DOI] [PubMed] [Google Scholar]
  6. Grufferman S., Duong T., Cole P. Occupation and Hodgkin's disease. J Natl Cancer Inst. 1976 Nov;57(5):1193–1195. doi: 10.1093/jnci/57.5.1193. [DOI] [PubMed] [Google Scholar]
  7. Gutensohn N., Cole P. Epidemiology of hodgkin's disease in the young. Int J Cancer. 1977 May 15;19(5):595–604. doi: 10.1002/ijc.2910190502. [DOI] [PubMed] [Google Scholar]
  8. Hardell L. Malignant lymphoma of histiocytic type and exposure to phenoxyacetic acids or chlorophenols. Lancet. 1979 Jan 6;1(8106):55–56. doi: 10.1016/s0140-6736(79)90509-9. [DOI] [PubMed] [Google Scholar]
  9. Hardell L., Sandström A. Case-control study: soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols. Br J Cancer. 1979 Jun;39(6):711–717. doi: 10.1038/bjc.1979.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoover R., Fraumeni J. F., Jr Risk of cancer in renal-transplant recipients. Lancet. 1973 Jul 14;2(7820):55–57. doi: 10.1016/s0140-6736(73)93256-x. [DOI] [PubMed] [Google Scholar]
  11. Infante P. F., Rinsky R. A., Wagoner J. K., Young R. J. Leukaemia in benzene workers. Lancet. 1977 Jul 9;2(8028):76–78. doi: 10.1016/s0140-6736(77)90074-5. [DOI] [PubMed] [Google Scholar]
  12. Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lenner P., Lundgren E., Damber L. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification. Acta Radiol Oncol Radiat Phys Biol. 1979;18(3):177–191. doi: 10.3109/02841867909128205. [DOI] [PubMed] [Google Scholar]
  14. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  15. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1189–1201. [PubMed] [Google Scholar]
  16. Miettinen O. S. Components of the crude risk ratio. Am J Epidemiol. 1972 Aug;96(2):168–172. doi: 10.1093/oxfordjournals.aje.a121443. [DOI] [PubMed] [Google Scholar]
  17. Miettinen O. S. Estimation of relative risk from individually matched series. Biometrics. 1970 Mar;26(1):75–86. [PubMed] [Google Scholar]
  18. Miettinen O. S. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969 Jun;25(2):339–355. [PubMed] [Google Scholar]
  19. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  20. Olin G. R., Ahlbom A. The cancer mortality among Swedish chemists graduated during three decades. A comparison with the general population and with a cohort of architects. Environ Res. 1980 Jun;22(1):154–161. doi: 10.1016/0013-9351(80)90127-9. [DOI] [PubMed] [Google Scholar]
  21. Seiler J. P. Phenoxyacids as inhibitors of testicular DNA synthesis in male mice. Bull Environ Contam Toxicol. 1979 Jan;21(1-2):89–92. doi: 10.1007/BF01685392. [DOI] [PubMed] [Google Scholar]
  22. Seiler J. P. The genetic toxicology of phenoxy acids other than 2,4,5-T. Mutat Res. 1978;55(3-4):197–226. doi: 10.1016/0165-1110(78)90004-0. [DOI] [PubMed] [Google Scholar]
  23. Vainio H., Päkkönen R., Rönnholm K., Raunio V., Pelkonen O. A study on the mutagenic activity of styrene and styrene oxide. Scand J Work Environ Health. 1976 Sep;2(3):147–151. doi: 10.5271/sjweh.2813. [DOI] [PubMed] [Google Scholar]
  24. Vianna N. J., Polan A. Lymphomas and occupational benzene exposure. Lancet. 1979 Jun 30;1(8131):1394–1395. doi: 10.1016/s0140-6736(79)92022-1. [DOI] [PubMed] [Google Scholar]
  25. Vigliani E. C., Forni A. Benzene and leukemia. Environ Res. 1976 Feb;11(1):122–127. doi: 10.1016/0013-9351(76)90115-8. [DOI] [PubMed] [Google Scholar]
  26. Vos J. G., Moore J. A., Zinkl J. G. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect. 1973 Sep;5:149–162. doi: 10.1289/ehp.7305149. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES